H
Hideaki Uchiyama
Researcher at Kyushu University
Publications - 357
Citations - 7970
Hideaki Uchiyama is an academic researcher from Kyushu University. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 39, co-authored 331 publications receiving 6621 citations. Previous affiliations of Hideaki Uchiyama include Keio University & French Institute for Research in Computer Science and Automation.
Papers
More filters
Journal ArticleDOI
Pose Estimation for Augmented Reality: A Hands-On Survey
TL;DR: This paper aims at presenting a brief but almost self-contented introduction to the most important approaches dedicated to vision-based camera localization along with a survey of several extension proposed in the recent years.
Journal ArticleDOI
Visual SLAM algorithms: a survey from 2010 to 2016
TL;DR: This paper focuses on vSLAM algorithms proposed mainly from 2010 to 2016 because major advance occurred in that period and the technical categories are summarized as follows: feature-based, direct, and RGB-D camera-based approaches.
Journal ArticleDOI
Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
Takashi Motomura,Ken Shirabe,Yohei Mano,Jun Muto,Takeo Toshima,Yuichiro Umemoto,Takasuke Fukuhara,Hideaki Uchiyama,Toru Ikegami,Tomoharu Yoshizumi,Yuji Soejima,Yoshihiko Maehara +11 more
TL;DR: Combined with the Milan criteria, NLR predicts outcomes after LDLT for HCC via the inflammatory tumor microenvironment and may be a new criterion for LDLT candidates with HCC.
Journal ArticleDOI
Sarcopenia is a prognostic factor in living donor liver transplantation
Toshiro Masuda,Ken Shirabe,Toru Ikegami,Norifumi Harimoto,Tomoharu Yoshizumi,Yuji Soejima,Hideaki Uchiyama,Tetsuo Ikeda,Hideo Baba,Yoshihiko Maehara +9 more
TL;DR: The incidence of postoperative sepsis was reduced even in patients with sarc Openia after the routine application of early enteral nutrition, and sarcopenia is an independent predictor of mortality andSepsis after LDLT.
Journal ArticleDOI
Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.
Takasuke Fukuhara,Akinobu Taketomi,Takashi Motomura,Shinji Okano,Akinori Ninomiya,Takayuki Abe,Hideaki Uchiyama,Yuji Soejima,Ken Shirabe,Yoshiharu Matsuura,Yoshihiko Maehara +10 more
TL;DR: In patients with recurrent HCV infection after orthotopic liver transplantation, combination analyses of single nucleotide polymorphisms of IL28B in recipient and donor tissues and mutations in HCV RNA allow prediction of SVR to PEG-IFN/RBV therapy.